HomeCompareXVIPY vs KO

XVIPY vs KO: Dividend Comparison 2026

XVIPY yields 30.58% · KO yields 2.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XVIPY wins by $102.8K in total portfolio value
10 years
XVIPY
XVIPY
● Live price
30.58%
Share price
$6.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$136.9K
Annual income
$18,414.99
Full XVIPY calculator →
KO
The Coca-Cola Company
● Live price
2.70%
Share price
$76.27
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,303.79
Full KO calculator →

Portfolio growth — XVIPY vs KO

📍 XVIPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXVIPYKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XVIPY + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XVIPY pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XVIPY
Annual income on $10K today (after 15% tax)
$2,599.39/yr
After 10yr DRIP, annual income (after tax)
$15,652.74/yr
KO
Annual income on $10K today (after 15% tax)
$229.58/yr
After 10yr DRIP, annual income (after tax)
$3,658.22/yr
At 15% tax rate, XVIPY beats the other by $11,994.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XVIPY + KO for your $10,000?

XVIPY: 50%KO: 50%
100% KO50/50100% XVIPY
Portfolio after 10yr
$85.5K
Annual income
$11,359.39/yr
Blended yield
13.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

XVIPY
No analyst data
Altman Z
4.9
Piotroski
6/9
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.3% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XVIPY buys
0
KO buys
0
No recent congressional trades found for XVIPY or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXVIPYKO
Forward yield30.58%2.70%
Annual dividend / share$2.00$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%24.3%
Portfolio after 10y$136.9K$34.1K
Annual income after 10y$18,414.99$4,303.79
Total dividends collected$94.1K$15.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: XVIPY vs KO ($10,000, DRIP)

YearXVIPY PortfolioXVIPY Income/yrKO PortfolioKO Income/yrGap
1← crossover$13,758$3,058.10$10,846$335.73+$2.9KXVIPY
2$18,653$3,932.12$11,829$430.64+$6.8KXVIPY
3$24,941$4,982.42$12,988$555.50+$12.0KXVIPY
4$32,914$6,226.19$14,372$721.34+$18.5KXVIPY
5$42,896$7,678.77$16,049$944.01+$26.8KXVIPY
6$55,252$9,353.04$18,114$1,246.74+$37.1KXVIPY
7$70,379$11,258.95$20,702$1,664.24+$49.7KXVIPY
8$88,708$13,403.14$24,008$2,249.48+$64.7KXVIPY
9$110,707$15,788.69$28,317$3,085.19+$82.4KXVIPY
10$136,871$18,414.99$34,065$4,303.79+$102.8KXVIPY

XVIPY vs KO: Complete Analysis 2026

XVIPYStock

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Full XVIPY Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this XVIPY vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XVIPY vs SCHDXVIPY vs JEPIXVIPY vs OXVIPY vs MAINXVIPY vs PEPXVIPY vs PGXVIPY vs JNJXVIPY vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.